Microsoft has made big changes to improve the accuracy and potential applications of Kinect. In a talk at GDC Next titled “The Next Generation of Kinect,” Microsoft senior program manager Ben Lower ...

Significant gains in the understanding of angles and angle measurements by elementary school students are seen in those who performed body-based tasks while interacting with a Kinect for Windows ...

Walt Disney is often talked about as the godfather of animation, but that honor truly belongs to two Frenchmen: Charles-Émile Reynaud projected the first animation onto a screen in 1877 and Émile Cohl ...

Despite plenty of initial skepticism, Kinect is proving to be a pretty cool gadget with lots of wow! power. Microsoft's motion-sensing device for the Xbox 360 — a device that lets you play video games ...

Microsoft's $150 Xbox add-on, the Kinect, can use face-recognition technology to log you onto your Xbox Live account. But it's not trouble-free. To understand why, you need to know how it works.

Australian entrepreneur Glenn Bilby helped found Quick Posture, a software for Microsoft's Xbox Kinect that can diagnose and help doctors manage movement-related diseases such as Parkinson's disease ...

Physical therapy researchers at Ohio State's Wexner Medical Center are developing a home therapy program for stroke patients, and the Xbox Kinect plays a central role. It involves a home-brewed game ...

Kinect is dead. The writing has been on the wall for years, at least since Microsoft de-bundled the motion-tracking system from the Xbox One in 2014, knocking $100 off the price tag and making the ...

Zombies don’t have to be scary – especially when kids can create them in their own image. Using the Kinect for Windows v2 sensor and an app called YAKiT, children can step into the role of the undead ...

Microsoft's next-generation Kinect will detect eye movement, a report has suggested. Using Kinect 2.0, users will apparently be able to pause entertainment content by looking away from the TV screen.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 3 KINECT®-DCP study evaluating the efficacy, safety, and tolerability of valbenazine in pediatric and adult participants who ...